CBio is excited to announce Kathleen Moore, MBA, President and Chief Operating Officer of CBio, will be speaking at the upcoming AES Electrophoresis Society conference in Atlanta, GA about commercialization and capital raising for complex electrophoresis based technology.
Kathleen has experience commercializing complex hardware and software systems She is currently regional sales manager of Akamai Technologies selling IT cyber security solutions and also pursuing her PhD in educational leadership at the University of New England.
Kathleen co-founded CBio in October 2016 with her brother David Charlot. David has a PhD in Bioengineering from UCSD and is an accomplished entrepreneur and hardware systems engineer. David previously co-founded an oncology diagnostics company in San Diego, CA and was president and CTO of the firm until April 2016. “I have always been fascinated with David’s science and the fast paced nature of innovation in academia. However, it was only after listening to him complain about the difficulty of commercializing new technology out of university did I realize the technologists are more focused on pushing the innovation envelope than solving customer problems” she says.
“I told David all we need is a smart business strategy around the innovation and we can help the world” she adds. It was after 2 months of conversation with David beginning in August 2016 discussing challenges with bringing complex electrokinetics technology to market that Kathleen mapped a commercial idea that is the basis of CBio.
“This is where I have helped shape the corporate strategy of CBio. Not only are the products we make innovative, they also solve critical challenges researchers face today associated with live cell analysis and will create tremendous value for our customers.
I’m excited because we’re helping fuel the next generation of diagnostics and drugs that will help people and save lives.”
Kathleen has proven success in large account management, leading sales teams, and establishing customer relationship programs to effectively target and leverage sales efforts. She has held roles of progressive leadership at Dell SecureWorks, most recently serving as Large Enterprise Sales Manager. She graduated from Wilmington University with an MBA in marketing. At CBio, she drives the commercial strategy to ensure product development supports customer needs and manages external relations.
About AES Electrophoresis Society
AES Electrophoresis Society is a unique, non-profit, international organization founded to advance and promote electric field-mediated separations, manipulations, and related phenomena. The field of electrokinetics intersects microfluidics and microdevices, biotechnology, theoretical modeling, material synthesis, nanotechnology and many others.
CBio is a life science tools company equipping researchers and clinicians with tools to help them identify predictive signatures of disease. Our proprietary cellPhoresis™ platform enables the study of living cells. Our technology identifies subtle differences between Normal and Abnormal living cells, preserves function, and retains usability for further study.